Your browser doesn't support javascript.
Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon ß-1b.
Hong, Sun In; Ryu, Byung-Han; Chong, Yong Pil; Lee, Seungjun; Kim, Sunjoo; Kim, Ho Cheol; Hong, Kyung-Wook; Bae, In-Gyu; Cho, Oh-Hyun.
  • Hong SI; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Ryu BH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Chong YP; Division of Infectious Diseases, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Lee S; Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Kim S; Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Kim HC; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Hong KW; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Bae IG; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
  • Cho OH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea; Gyeongsang Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, Republic of Korea. Electronic addres
Int J Antimicrob Agents ; 56(2): 106052, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: covidwho-601373
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Adyuvantes Inmunológicos / Infecciones por Coronavirus / Quimioterapia Combinada / Betacoronavirus / Antimaláricos Tipo de estudio: Reporte de caso / Estudio pronóstico Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged Idioma: Inglés Revista: Int J Antimicrob Agents Año: 2020 Tipo del documento: Artículo

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Adyuvantes Inmunológicos / Infecciones por Coronavirus / Quimioterapia Combinada / Betacoronavirus / Antimaláricos Tipo de estudio: Reporte de caso / Estudio pronóstico Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged Idioma: Inglés Revista: Int J Antimicrob Agents Año: 2020 Tipo del documento: Artículo